FormDSignal
30

Andira Medicine Inc. closes $120K raise in North Vancouver

Company raise · Closed · North Vancouver, British Columbia, Canada · Form D filed 2026-10-09

Andira Medicine Inc., a British Columbia corporation, raised $120K under Regulation D exemption 6(b). The offering closed on September 24, 2026, with one investor and North Point Mergers and Acquisitions listed as placement agent.

Note: Micro-sized raise ($120K) with single investor; verify investor accreditation status given exemption 6(b) and minimal documentation trail.

Placement agent engagedoperating_company

How this compares

  • No earlier fund launch by this sponsor appears on EDGAR.

Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.

Raise progress

FiledFormSoldInvestorsChange
2025-09-05D/A$810K5
2026-03-12D$152K3−$658K
2026-08-18D$100K1−$52K
2026-09-04D/A$810K5+$710K
2026-10-09D$120K1−$690K

Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.

Andira Medicine on EDGAR

Earlier and related filings by the same issuer and sponsor.

15

Andira Medicine Inc. files Form D

Company raise update · Raising · Offering $1.6M · Sold $810K · North Vancouver, British Columbia, Canada · filed 2026-09-04

Sold rose to $NaN (+$710K, +4 investors) in 17 days since the previous filing.

People on the filing

Dana LambertDirector, Executive Officer
Ethan RussoDirector, Executive Officer
Michael Stuart WallDirector, Executive Officer
Ammad ShorbajiExecutive Officer
Janette LyonsExecutive Officer

Signed by Dana Lambert, CEO.

Placement agents / sales compensation: North Point Mergers and Acquisitions, Inc.

Why now — by persona

  • Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans.